LFG
MNOV icon

Larson Financial Group’s MediciNova MNOV Stock Holding History

Larson Financial Group’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7 Buy
+5
New +$7 ﹤0.01% 3744

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Larson Financial Group's MNOV Position: Q2 2026 in Review

Larson Financial Group opened a new position in MediciNova (MNOV) in Q2 2026: 5 shares worth $7. The stake represents ﹤0.01% of the portfolio and ranks #3744 among its holdings.

29 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

  • Larson Financial Group held 5 shares of MediciNova worth $7 as of Q2 2026.
  • MediciNova was a new Larson Financial Group position in Q2 2026.
  • MediciNova made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3744 holding.
  • 29 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.